Otomycosis References

  1. Andral G, Gavarret J. Ann Chim Phys. 1843; 88.
  2. Mayer AFJK. Beobachtung von Cysten mit Fadenpilzen aus dem aussern Gehorgange eines Madchens. Arch Anat Physiol. Wissench Med. 1844; 11: 404-8.
  3. Galloway DJ. Otomycosis of the Malay Archipelago. J Laryngol. 1903; 64-70.
  4. Cheatle A. Otomycosis. J Laryngol Rhinol Otol. 1920; 35: 3-4.
  5. Wolf FT. Relation of various fungi to otomycosis. Arch Otolaryngol. 1947; 46: 361-74.
  6. English MP. Otomycosis caused by a ringworm fungus. J Laryngol Otol. 1957; 71: 207-8.
  7. Lakshmipati G, Murti RB. Otomycosis. J Indian Med Assoc. 1960; 34: 439-41.
  8. Agnihotri VP. Aspergilli causing otomycosis. Die Natur. 1961; 702.
  9. Gregson AEW, La Touche CJ. Otomycosis: A neglected disease. J Laryngol Otol. 1961a; 75: 45-69.
  10. Gregson AEW, La Touche CJ. The significance of mycotic infections in the etiology of otitis externa. J Laryngol Otol. 1961b; 75: 167-70.
  11. Ismail HK. Otomycosis. J Laryngol Otol, 1962; 76: 713-21.
  12. Yassin A, Mostofa MA, Moawad MK. Fungus infection of the ear. J Laryngol Otol. 1964; 78: 591-602.
  13. Damato PJ. Treatment of otomycosis due to A. niger. The St Lukes Hosp Gaz. 1966; 1: 66-88.
  14. Beaney GPE, Broughton A. Tropical otomycosis. J Laryngol Otol. 1967; 81: 987-97.
  15. McGonigle JJ, Jillson OF. Otomycosis: an entity. Arch Dermatol. 1967; 95: 45-6.
  16. Sood VP, Sinha A, Mohapatra LN. Otomycosis: A clinical entity - clinical and experimental study. J Laryngol Otol. 1967; 81: 999-1004.
  17. Youssef YA, Abdou MH. Studies on fungus infection of the external ear. I. Mycological and clinical observations. J Laryngol Otol. 1967a; 81: 401-12.
  18. Youssef YA, Abdou MH. Studies on fungus infection of the external ear. II. On the chemotherapy of otomycosis. J Laryngol Otol. 1967b; 81: 1005-12.
  19. Chandler J R. Malignant external otitis. Laryngoscope. 1968; 78: 1257-94.
  20. Yamashita K. [Fungus diseases in otolaryngology, with special reference to otomycosis] Iryo. 1969; 23: 1233-40. Japanese.
  21. Bezjak V, Arya OP. Otomycosis due to Aspergillus niger. East Afr Med J. 1970; 47: 247-53.
  22. Civila ES, Tost JF, Jimenez AL, Conti-Diaz IA. Root-like hyphal structures in aspergillar otomycosis. Arq Inst Biol (Sao Paulo). 1972; 39: 137-9.
  23. Damato PJ. Therapy with tolnaftate in otomycosis due to Aspergillus niger. Minerva Med (Italian). 1973; 64: 24-6.
  24. Schonebeck J, Zakrisson JE. Topical 5-fluorocytosine therapy in otomycosis. J Laryngol Otol. 1974; 88: 227-31.
  25. Meunier A, Blassin R, Meunier F. Remarquable efficacite due to naftate sur les otomycoses (30 observations). Annales D’otolaryngol (Paris). 1975; 92: 699-702.
  26. Kley E. A contribution to the treatment of otomycosis. Laryngol Rhinol Otol. 1976; 55: 765-7.
  27. Lawrence TL, Ayers LW, Saunders WH. Drug therapy in otomycosis: an in vitro study. Laryngoscope. 1978; 88: 1755-60.
  28. Sengupta RP, Kacker SK. Otomycosis. Indian J Med Sci. 1978; 32: 5-7.
  29. Yassin A, Maher A, Moawad MK. Otomycosis : a survey in the eastern province of Saudi Arabia. J Laryngol Otol. 1978; 92: 869-876.
  30. Caruso VG. When the patient has otitis externa. Geriatrics. 1980; 35: 35-42.
  31. Joy MJ, Agarwal MK, Samant HC. Mycological and bacteriological studies in otomycosis. Indian J Otolaryngol. 1980; 32: 72-5.
  32. Lopez L, Evens RP. Drug therapy of Aspergillus otitis externa. Otolaryngol Head Neck Surg. 1980; 88: 649-51.
  33. Than KM, Naing KS, Min M. Otomycosis in Burma and its treatment. Am J Trop Med Hyg. 1980; 29: 620-3.
  34. Schneider ML. Merthiolate in treatment of otomycosis. Laryngoscope. 1981; 91: 1194-5.
  35. Maher A, Bassiouny A, Moawad MK, Hendawy DS. Otomycosis: an experimental evaluation of six antimycotic agents. J Laryngol Otol. 1982; 96: 205-13.
  36. Pahwa VK, Chamiyal PC, Suri PN. Mycological study in otomycosis. Indian J Med Res. 1983; 77: 334-8.
  37. Falser N. Fungal infection of the ear: Etiology and therapy with bifonazole cream or solution. Dermatologica. 1984; 169 (Suppl. 1): 135-40.
  38. Kopstein E. Otitis externa: unorthodox but effective treatments. Laryngoscope. 1984; 94: 1248.
  39. Oliveri S, Capello G, Napolitano MG, Triolo C, Grillo C. Otomicosi: etiologia ed analisi di alcuni fattori predisponenti. Boll Ist Sieroter Milan. 1984; 63: 537-42.
  40. Mugliston T, O’Donoghue G. Otomycosis - a continuing problem. J Laryngol Otol. 1985; 99: 327-33.
  41. Petrak N, Pottage JC, Levin S. Invasive external otitis caused by Aspergillus fumigatus in an immunocompromised patient. J Infect Dis. 1985; 151: 196.
  42. Bassiouny A, Kamel T, Moawad MK, Hindawy DS. Broad-spectrum antifungal agents in otomycosis. J Laryngol Otol. 1986;100: 867-73.
  43. Kwok P, Hawke M. Clotrimazole powder in the treatment of otomycosis. J Otolaryngol. 1987; 16: 98.
  44. Bickley LS, Betts RF, Parkins CW. Atypical invasive external otitis from Aspergillus. Arch Otolaryngol Head Neck Surg. 1988; 114: 1024-8.
  45. Cunningham M, Yu VL, Turner J, Curtin H. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg. 1988; 114: 554-6.
  46. Talwar P, Chakrabarti A, Kaur P, Pahwa RK, Mittal A, Mehra YN. Fungal infection of ear with special reference to chronic suppurative otitis media. Mycopathologia. 1988; 104: 47-50.
  47. Stern JC, Lucente FE. Otomycosis. Ear Nose Throat J. 1988; 67: 804-10.
  48. Stern JC, Shah MK, Lucente FE. In vitro effectiveness of 13 agents in otomycosis and review of the literature. Laryngoscope. 1988; 98: 1173-7.
  49. Ette A, Bamba M, Adjoua P, Boguifo J, Ette EE, Fakhry K, Therizol MF. Mycoses in otorhinolaryngology. Apropos of 167 cases. Rev Laryngol Otol Rhinol (Bord). 1989; 110: 173-7.
  50. Gugnani HC, Okafor BC, Nzelibe F, Njoku-Obi AN. Etiological agents of otomycosis in Nigeria. Mycoses. 1989; 32: 224-9.
  51. Marsh RR, Tom LW. Ototoxicity of antimycotics. Otolaryngol Head Neck Surg. 1989; 100: 134-6.
  52. Paulose KO, Al Khalifa S, Shenoy P, Sharma RK. Mycotic infection of the ear (otomycosis): a prospective study. J Laryngol Otol. 1989; 103: 30-5.
  53. Piantoni S, Narne S, Bottin R, Solazzo A, Bianchi W. 1% bifonazole lotion in the therapy of otomycosis. Clin Ter.1989; 130: 23-7.
  54. Cohen SR, Thompson JW. Otitic candidiasis in children: an evaluation of the problem and effectiveness of ketoconazole in 10 patients. Ann Otol Rhinol Laryngol. 1990; 99: 427-31.
  55. Menachof M R, Jackler RK. Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryngol Head Neck Surg. 1990; 102: 285-9.
  56. Philips P, Bryce G, Shepherd J, Mintz D. Invasive external otitis caused by Aspergillus. Rev Infect Dis. 1990; 12: 277-81.
  57. Yehia MM, Al-Habib HM, Shehab NM. Otomycosis: a common problem in North Iraq. J Laryngol Otol. 1990; 104: 387-9.
  58. Gintautiene K, Lamarca C, Duvalsaint F, Chaudhry MR, Tadoori P, Abadir AR, Gintautas J. Effect of ketoconazole on external otitis. Proc West Pharmacol Soc. 1991; 34: 351-2.
  59. Reiss P, Hadderingh R, Schot LJ, Danners SA. Invasive external otitis caused by Aspergillus fumigatus in two patients with AIDS. AIDS. 1991; 5: 605-6.
  60. Strauss M, Fine E. Aspergillus otomastoiditis in acquired immunodeficiency syndrome. Am J Otol. 1991; 12: 49-53.
  61. Zaror L, Fischman O, Suzuki FA, Felipe RG. Otomycosis in Sao Paulo. Rev Inst Med Trop Sao Paulo. 1991; 33: 169-73.
  62. Jesenska Z, Durkovsky J, Rosinsky J, Polak M, Zamboova E, Baca B. Filamentous micromycetes in otitis. Cesk Epidemiol Mikrobiol Imunol. 1992; 41: 337-41.
  63. Kawamura T, Ikeda H, Nakasato N, Ogawa A, Yoshimoto T. A case of intracerebral epidermoid associated with aspergillosis. No Shinkei Geka. 1992; 20: 463-7.
  64. Murai H, Kira J, Kobayashi T, Goto I, Inoue H, Hasuo K. Hypertrophic cranial pachymeningitis due to Aspergillus flavus. Clin Neurol Neurosurg. 1992; 94: 247-50.
  65. Comacchio F, D’Eredita R, Bison E, Chierichetti F, Ferlin G, Marchiori C. Value of TC99m-Nanocolloid spect in diagnosis and follow-up of necrotizing external otitis. Acta Otorhinolaryngol Ital. 1993; 13: 517-24.
  66. Del Palacio A, Lopez-Suso M J, Moore MK, Cuetara MS, Garcia-La Calle C, Noriega AR. Long-term follow-up of otomycosis and its treatment with bifonazole. J Med Vet Mycol. 1993; 31: 435-47.
  67. Garcia-Martos P, Delgado D, Marin P, Mira J. Analisis de 40 casos de otomicosis. Enferm Infecc Microbiol Clin. 1993; 11: 487-9.
  68. Hall PJ, Farrior JB. Aspergillus mastoiditis. Otolaryngol Head Neck Surg. 1993; 108: 167-70.
  69. Lucente FE. Fungal infections of the external ear. Otolaryngol Clin North Am. 1993; 26: 995-1006.
  70. Sheikh MS, Quzi By, Rammen B. Otomycosis in Khozistan. Indian J Otolaryngol Head Neck Surg. 1993; 2: 73-7.
  71. Bayo M, Agut M, Calvo MA. Infectious external otitis: etiology in the Terrassa region, culture methods and considerations on otomycosis. Microbiologia. 1994; 10: 279-84.
  72. Bennett JE. Fungi as a cause of otitis. JAMA. 1994; 271: 1628.
  73. Gordon G, Giddings NA. Invasive otitis externa due to Aspergillus species: case report and review. Clin Infect Dis. 1994; 19: 866-70.
  74. Grandis JR, Kamerer DB, Gates GA, eds. External otitis. In: Current therapy in Otolaryngology - Head & Neck Surgery. 5th ed. St Louis Mo: CV Mosby Co. 1994; 2-3.
  75. Haruna S, Haruna Y, Schachern PA, Morizono T, Paparella MM. Histopathology update: otomycosis. Am J Otolaryngol. 1994; 15: 74-8.
  76. Jain SK, Agrawal SC. Fungitoxic effect of some organic volatile substances against fungi causing otomycosis. Mycoses. 1994; 37: 299-301.
  77. Kikuchi A, Funakubo T, Kohsyu H. A study of fungal infections in otorhinolaryngology. Acta Otolaryngol (Stockh). 1994; 51: 224-7.
  78. Kintzel PE, Trausch DE, Copfer AL. Otic administration of amphotericin B 0.25% in sterile water. Ann Pharmacother. 1994; 28: 333-5.
  79. Dhindsa MK, Naidu J, Singh SM, Jain SK. Chronic suppurative otitis media caused by Paecilomyces variotii. J Med Vet Mycol. 1995; 33: 59-61.
  80. Harley WB, Dummer JS, Anderson TL, Goodman S. Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs. Clin Infect Dis. 1995; 20: 1052-4.
  81. Patow CA. Fungi as a cause of otitis. JAMA. 1995; 273: 25.
  82. Tisner J, Millan J, Rivas P, Adiego I, Castellote A, Valles H. Otomycosis and topical application of thimerosal: study of 152 cases. Acta Otorinolaringol Esp. 1995; 46: 85-9.
  83. Tiwari S, Singh SM, Jain S. Chronic bilateral suppurative otitis media caused by Aspergillus terreus. Mycoses. 1995; 38: 297-300.
  84. Chander J, Maini S, Subhramanyan S, Handa A. Otomycosis: a clinico-mycological study and efficacy of mercurochrome in its treatment. Mycopathologia. 1996; 135: 9-12.
  85. Lohoue-Petmy J, Bengono-Toure G, Founda-Onana A. A study of otomycoses in Yaounde. Rev Laryngol Otol Rhinol. 1996; 117: 119-21.
  86. Bryce GE, Phillips P, Lepawsky M, Gribble MJ. Invasive Aspergillus tympanomastoiditis in an immunecompetent patient. J Otolaryngol. 1997; 26: 266-9.
  87. Enweani IB, Igumbor H. Prevalence of otomycosis in malnourished children in Edo State, Nigeria. Mycopathologia. 1997-98; 140: 85-7.
  88. Gurr PA, Evans K, Dewey FM, Gurr SJ. Otomycosis: the detection of fungi in ears by immunofluorescence microscopy. Clin Otolaryngol. 1997; 22: 275-83.
  89. Ibekwe AO, al-Shareef Z, Benayam A. Anaerobes and fungi in chronic suppurative otitis media. Ann Otol Rhinol Laryngol. 1997; 106: 649-52.
  90. Pak MW, Soo G, van Hasselt CA. Flourishing otomycosis. Ear Nose Throat J. 1997; 76: 10.
  91. Yates PD, Upile T, Axon PR, de Carpentier J. Aspergillus mastoiditis in a patient with acquired immunodeficiency syndrome. J Laryngol Otol. 1997; 111: 560-1.
  92. Munoz A, Martinez-Chamorro E. Necrotizing external otitis caused by Aspergillus fumigatus: computed tomography and high resolution magnetic resonance imaging in an AIDS patient. J Laryngol Otol. 1998; 112: 98-102.
  93. Chen D, Lalwani AK, House JW, Choo D. Aspergillus mastoiditis in acquired immunodeficiency syndrome. Am J Otol. 1999; 20: 561-7.
  94. Nong H, Li J, Huang G, Nong D, Cheng P, Yao C. The observation of mycology and clinical efficacy in 325 cases with otomycosis. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 1999; 13: 438-40.
  95. Dyckhoff G, Hoppe-Tichy T, Kappe R, Dietz A. Antimycotic therapy in otomycosis with tympanic membrane perforation. Hno. 2000; 48: 18-21.
  96. Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinico-mycologic study. Ear Nose Throat J. 2000; 79: 606-9.
  97. Khanna V, Chander J, Nagarkar NM,Dass A. Clinico-microbiological evaluation of active tubotympanic type chronic suppurative otitis media. J Otolaryngol. 2000; 29: 148-53.
  98. Tom LW. Ototoxicity of common topical antimycotic preparations. Laryngoscope. 2000; 110: 509-16.
  99. Gopalakrishnan S, Chadha SK, Gopalan G, Ravi D. Role of mastoid obliteration in patients with persistent cavity problems following modified radical mastoidectomy. J Laryngol Otol. 2001; 115: 967-72.
  100. Hurst WB. Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol. 2001; 115: 879-80.
  101. Jinn TH, Kim PD, Russell PT, Church CA, John EO, Jung TT. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells. Laryngoscope. 2001; 111: 2105-8.
  102. Kurnatowski P, Filipiak A. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses. 2001; 44: 472-9.
  103. Mgbor N, Gugnani HC. Otomycosis in Nigeria: treatment with mercurochrome. Mycoses. 2001; 44: 395-7.
  104. Nwabuisi C, Ologe FE. The fungal profile of otomycosis patients in Ilorin, Nigeria. Niger J Med. 2001; 10: 124-6.
  105. Rotoli M, Sascaro G, Cavalieri S. Aspergillus versicolor infection of the external auditory canal successfully treated with terbinafine. Dermatology. 2001; 202: 143.
  106. Deguine C, Pulec JL. Otomycosis with pus. Ear Nose Throat J. 2002; 81: 428.
  107. del Palacio A, Cuetara MS, Lopez-Suso MJ, Amor E, Garau M. Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis. Mycoses. 2002; 45: 317-28.
  108. Finer G, Greenberg D, Leibovitz E, Leiberman A, Shelef I, Kapelushnik J. Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in a neutropenic patient. Scand J Infect Dis. 2002; 34: 227-9.
  109. Jain SK, Agrawal SC, Jain PC. In vitro evaluation of sulfa drugs against fungi causing otomycosis. Hindustan Antibiot Bull. 2002; 44: 42-6.
  110. Ologe FE, Nwabuisi C. Treatment outcome of otomycosis in Ilorin, Nigeria. West Afr J Med. 2002; 21: 34-6.
  111. Pulec JL, Deguine C. Otomycosis. Ear Nose Throat J. 2002; 81: 370.
  112. Vennewald I, Schönlebe J, Klemm E. Histologic studies on otomycosis. Mycoses. 2002; 45 (Suppl. 1): 47-52.
  113. Bellini C, Antonini P, Ermanni S, Dolina, Passega E, Bernasconi E. Malignant otitis externa due to Aspergillus niger. Scand J Infect Dis. 2003; 35: 284-8.
  114. Ozcan KM, Ozcan M, Karaarslan A, Karaarslan F. Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol. 2003; 117: 39-42.
  115. Ozcan M, Ozcan KM, Karaarslan A, Karaarslan F. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Arch Otorhinolaryngol. 2003; 260: 24-7.
  116. Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol. 2003; 112: 384-7.
  117. Schrader N, Isaacson G. Fungal otitis externa - its association with fluoroquinolone eardrops. Pediatrics. 2003; 111: 1123.
  118. Supiyaphun P, Sampatanukul P, Vongfu S, Kerekhanjanarong V. Aural aspergilloma: an unusual delayed complication of tympanoplasty. J Med Assoc Thai. 2003; 86 (Suppl. 2): S358-61.
  119. Vennewald I, Schonlebe J, Klemm E. Mycological and histological investigations in humans with middle ear infections. Mycoses. 2003; 46: 12-8.
  120. Harima N, Inoue T, Kubota T, Okada O, Ansai S, Manabe M, Ichinoe M, Kasai T. A case of otomycosis caused by Aspergillus sclerotiorum. J Dermatol. 2004; 31: 949-50.
  121. Karaarslan A, Arikan S, Ozcan M, Ozcan KM. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis. Mycoses. 2004; 47: 284-7.
  122. Mishra GS, Mehta N, Pal M. Chronic bilateral otomycosis caused by Aspergillus niger. Mycoses. 2004; 47: 82-4.
  123. Ogunleye AO, Awobem AA. Trends of ear syringing at Ibadan, Nigeria. Afr J Med Med Sci. 2004; 33: 35-7.
  124. Rubin Grandis J, Branstetter BFT, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological and anatomic correlations. Lancet Infect Dis. 2004; 4: 34-9.
  125. van Hasselt P, Gudde H. Randomized controlled trial on the treatment of otitis externa with one per cent silver nitrate gel. J Laryngol Otol. 2004; 118: 93-6.
  126. Amonoo-Kuofi K, Tostevin P, Knight JR. Aspergillus mastoiditis in a patient with systemic lupus erythematosus: a case report. Skull Base. 2005; 15: 109-12.
  127. Chang CY, Schell WA, Perfect JR, Hulka GF. Novel use of a swimming pool biocide in the treatment of a rare fungal mastoiditis. Laryngoscope. 2005; 115: 1065-9.
  128. Hueso Gutierrez P, Jimenez Alvarez S, Gil-Carcedo Sanudo E, Gil-Carcedo Garcia LM, Ramos Sanchez C, Vallejo Valdezate LA. Presumption diagnosis: otomycosis. A 451 patients study. Acta Otorrinolaringol Esp. 2005; 56: 181-6.
  129. Jackman A, Ward R, April M, Bent J. Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol. 2005; 69: 857-60.
  130. Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2005; 69: 1503-8.
  131. Morinaka S. Dermatophytosis of the ear. Otolaryngol Head Neck Surg. 2005; 133: 113-5.
  132. Wang MC, Liu CY, Shiao AS, Wang T. Ear problems in swimmers. J Chin Med Assoc. 2005; 68: 347-52.
  133. Araiza J, Canseco P, Bonifaz A. Otomycosis: clinical and mycological study of 97 cases. Rev Laryngol Otol Rhinol (Bord). 2006; 127: 251-4.
  134. Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006; 135: 787-91.
  135. Hoshino T, Matsumoto M. Otomycosis: subdermal growth in calcified mass. Eur Arch Otorhinolaryngol. 2006; 263: 875-8.
  136. Narozny W, Kuczkowski J, Stankiewicz C, Kot J, Mikaszewski B, Przewozny T. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol. 2006; 263: 680-4.
  137. Osguthorpe JD, Nielsen DR. Otitis externa: review and clinical update. Am Fam Physician. 2006; 74: 1510-6.
  138. Tuzcu A, Bahceci M, Celen MK, Kiline N, Ozmen S. Necrotizing (malignant) otitis externa: an unusual localization of mucormycosis. Indian J Med Microbiol. 2006; 24: 289-91.
  139. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2007; 51: 67-70.
  140. Hutchin M, Chenoweth C, Ma L, McClean K. Auricular erythema with nodules and scale. Arch Dermatol. 2007; 143: 1441-6.
  141. Kaya AD, Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007; 50: 447-50.
  142. Kiakojuri K, Roushan MR, Sepidgar SA. Suction clearance and 2% topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian J Trop Med Public Health. 2007; 38: 749-53.
  143. Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008; 41: 537-49.
  144. Ling SS, Sader C. Fungal malignant otitis externa treated with hyperbaric oxygen. Int J Infect Dis. 2008; 12: 550-2.
  145. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: A review. Int J Pediatr Otorhinolaryngol. 2008; 72: 453-9.
  146. Parize P, Chandesris MO, Lanternier F, Poiree S, Viard JP, Bienvenu B, Mimoun M, Mechai F, Mamzer MF, Herman P, Bougnoux ME, Lecuit M, Lortholary O. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review. Antimicrob Agents Chemother. 2008.
  147. Rutt AL, Sataloff RT. Aspergillus otomycosis in an immunocompromised patient. Ear Nose Throat J. 2008; 87: 622-3.
  148. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008; 5: e219.

back to otomycosis